CXCL9, a promising biomarker in the diagnosis of chronic Q fever
نویسندگان
چکیده
منابع مشابه
CXCL9, a promising biomarker in the diagnosis of chronic Q fever
BACKGROUND In the aftermath of the largest Q fever outbreak in the world, diagnosing the potentially lethal complication chronic Q fever remains challenging. PCR, Coxiella burnetii IgG phase I antibodies, CRP and 18F-FDG-PET/CT scan are used for diagnosis and monitoring in clinical practice. We aimed to identify and test biomarkers in order to improve discriminative power of the diagnostic test...
متن کاملQ fever a Forgotten Disease in Iran
There have already been a few studies on Q fever in Iran and most of them go back to more than 50 years ago. Preliminary serologic studies on ruminants and febrile patients in Southeast Iran show a high seropositivity in this region. Misdiagnosis as well as poor attention of public health authorities to this infection can facilitate the epidemic spread of Q fever. Further studies on the diagnos...
متن کاملEnzyme-linked immunosorbent assay for diagnosis of chronic Q fever.
From 1982 through 1987 we diagnosed 13 chronic Q fever cases. Clinically these patients presented a culture-negative endocarditis, and all but two had high complement-fixing antibody titers to Coxiella burnetii phase I (reciprocal titer above 200). With the enzyme-linked immunosorbent assay (ELISA), titers of immunoglobulin G (IgG) to phases I and II of C. burnetii averaged 158,000 and 69,900, ...
متن کاملDelayed Diagnosis of Chronic Q Fever and Cardiac Valve Surgery
Untreated chronic Q fever causes a high number of complications and deaths. We present cases of chronic Q fever that were not diagnosed until after the patients underwent cardiac valve surgery. In epidemic areas, Q fever screening of valve surgery patients secures early initiation of treatment and can prevent illness and death.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Infectious Diseases
سال: 2017
ISSN: 1471-2334
DOI: 10.1186/s12879-017-2656-6